The Intelligent Content Life Sciences event was held in our backyard at San Francisco this week. Organized by Ann Rockley of the Rockley Group and Scott Abel, Content Wrangler this was a great opportunity for us to meet people from Life Sciences organizations, discuss the challenges they face and how we might deliver value.
Our Founder and CEO, Paul Trotter spoke to a packed audience on Global Reuse of Medical Information and Improved Customer Experiences while I did a short presentation on our business and how we are supporting the Life Sciences industries. Patrick Welsh, VP Vertical Solutions Life Sciences rounded out our team for the event.
Although it was small at around 100 attendees, I thought the interest in exploring best practice content strategies and intelligent content was strong. The attendees seemed to be very aware of the content challenges that they face but this is balanced by the fact that they are inherently risk adverse and somewhat battle scarred from previous failed attempts to solve their content and documentation issues.
Our message is definitely resonating and I feel that Life Sciences companies really have no option but to get serious about addressing their content authoring and management issues.
Our message is really quite simple, Life Science companies produce two things…. Drugs or Devices… and documents. By the time a new drug or device hits the market, billions have been invested in research, development, manufacturing process, medical information and regulatory approvals. A significant portion of this huge investment is represented as content. And in this, lies the challenges.
For too long now Life Sciences companies have been held back by outdated document based processes, systems and tools. This means that they struggle to maintain a single source of truth and this becomes a compliance nightmare, particularly in regard to market facing and regulatory content. Updating content is a painful exercise of finding the correct content plus every document or online format in which that content exists. As a result, content development and updates are repetitive and error-prone exercises. Obviously a new… more intelligent content approach is required.
And this is the crux of our offer to the Life Sciences industries… a more intelligent approach. Our approach has been refined over more than 15 years of delivering single source, component authoring, management and publishing solutions for a wide variety of industries around the world. In the past three years, we have migrated to SaaS and Cloud delivery and specialized Author-it Cloud for Life Sciences applications in Medical Communications, Labeling and Med Device Technical Communications.
We have put an enormous amount of work into the design and user experience for our Life Sciences clients. This industry will not tolerate complexity. Systems need to be intuitive and easy to use. Writers don’t wantto contend with coding, complicated XML tagging or confusing new processes. Instead, they need to be able to concentrate on quickly and efficiently delivering their content using a single source, component authoring approach. The results are compelling. Lower call center costs, a better and faster customer experience for physicians, lower content production and update costs and more consistent content reducing regulatory issues and risk.
Next up for us is the Veeva Commercial Summit in Philadelphia May 19-21. We have a large team attending and are looking forward to “mixing it up” with Life Sciences attendees and working with Veeva and our other partners at this event.